The Cambridge-based startup is aimed at furthering technologies in "immuno-oncology" – drugs that tackle the immune system to better attack cancer cells.
You have no items in your shopping cart.
LOGIN OR CREATE NEW ACCOUNT
Tag: Pharmaceuticals
-
Apparently EpiPen Maker Mylan Hiked Prices on a Variety of Other Medications As Well
Mylan’s CEO Heather Bresch, who saw her compensation increase by nearly 700% from 2007 to 2015, could draw "greater regulatory scrutiny and headline risk" as a result of such price increases.
-
Mylan's EpiPen4Schools Under Further Investigation For Antitrust Violation
Mylan has previously fought against its competitor Teva Pharmaceutical Industries' application to the FDA for approval of its generic EpiPen
per page
Socialize With Us
